ArticleOncoimmunology
Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity.
Sophie Langdon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
trialcites it
ArticleOncoimmunology
Sophie Langdon et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.